Allied Investment Advisors, LLC Abbott Laboratories Transaction History

Allied Investment Advisors, LLC

  • $505 Million
  • Q3 2024

A detailed history of Allied Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Allied Investment Advisors, LLC holds 84,743 shares of ABT stock, worth $9.98 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares
84,743
Previous 82,518 2.7%
Holding current value
$9.98 Million
Previous $8.57 Million 12.68%
% of portfolio
1.91%
Previous 2.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024
BUY
$100.07 - $118.13 $222,655 - $262,839
2,225 Added 2.7%
84,743 $9.66 Million
Q2 2024

Jul 12, 2024
BUY
$100.73 - $112.44 $295,743 - $330,123
2,936 Added 3.69%
82,518 $8.57 Million
Q1 2024

Apr 11, 2024
BUY
$109.52 - $120.96 $421,213 - $465,212
3,846 Added 5.08%
79,582 $9.05 Million
Q4 2023

Jan 09, 2024
BUY
$90.19 - $110.4 $132,849 - $162,619
1,473 Added 1.98%
75,736 $8.34 Million
Q3 2023

Oct 05, 2023
BUY
$95.53 - $114.62 $305,887 - $367,013
3,202 Added 4.51%
74,263 $7.19 Million
Q2 2023

Jul 10, 2023
BUY
$100.78 - $112.29 $142,200 - $158,441
1,411 Added 2.03%
71,061 $7.75 Million
Q1 2023

Apr 17, 2023
BUY
$96.86 - $114.01 $185,293 - $218,101
1,913 Added 2.82%
69,650 $7.05 Million
Q4 2022

Jan 12, 2023
BUY
$95.06 - $111.52 $168,731 - $197,948
1,775 Added 2.69%
67,737 $0
Q3 2022

Oct 13, 2022
BUY
$96.76 - $112.03 $218,387 - $252,851
2,257 Added 3.54%
65,962 $6.38 Million
Q2 2022

Jul 13, 2022
BUY
$102.07 - $123.37 $187,604 - $226,754
1,838 Added 2.97%
63,705 $6.92 Million
Q1 2022

Apr 11, 2022
BUY
$114.02 - $139.04 $326,211 - $397,793
2,861 Added 4.85%
61,867 $7.32 Million
Q4 2021

Jan 20, 2022
BUY
$115.53 - $141.46 $82,603 - $101,143
715 Added 1.23%
59,006 $8.31 Million
Q3 2021

Oct 13, 2021
SELL
$116.66 - $129.06 $25,781 - $28,522
-221 Reduced 0.38%
58,291 $6.89 Million
Q2 2021

Jul 16, 2021
BUY
$105.79 - $124.53 $168,206 - $198,002
1,590 Added 2.79%
58,512 $6.78 Million
Q1 2021

Apr 20, 2021
BUY
$108.84 - $128.23 $124,730 - $146,951
1,146 Added 2.05%
56,922 $6.82 Million
Q4 2020

Jan 19, 2021
SELL
$105.0 - $114.42 $68,880 - $75,059
-656 Reduced 1.16%
55,776 $6.11 Million
Q3 2020

Oct 13, 2020
SELL
$91.64 - $111.29 $140,484 - $170,607
-1,533 Reduced 2.64%
56,432 $6.14 Million
Q2 2020

Jul 10, 2020
SELL
$76.57 - $98.0 $257,198 - $329,182
-3,359 Reduced 5.48%
57,965 $5.3 Million
Q1 2020

Apr 17, 2020
SELL
$62.82 - $91.86 $17,463 - $25,537
-278 Reduced 0.45%
61,324 $4.84 Million
Q4 2019

Jan 24, 2020
BUY
$78.51 - $87.4 $46,713 - $52,003
595 Added 0.98%
61,602 $5.35 Million
Q3 2019

Oct 17, 2019
SELL
$81.84 - $88.74 $14,322 - $15,529
-175 Reduced 0.29%
61,007 $5.1 Million
Q2 2019

Jul 17, 2019
SELL
$72.88 - $85.0 $58,449 - $68,170
-802 Reduced 1.29%
61,182 $5.15 Million
Q1 2019

Apr 22, 2019
SELL
$66.22 - $80.06 $154,954 - $187,340
-2,340 Reduced 3.64%
61,984 $4.96 Million
Q4 2018

Feb 01, 2019
BUY
$65.56 - $74.27 $89,817 - $101,749
1,370 Added 2.18%
64,324 $4.65 Million
Q3 2018

Oct 23, 2018
BUY
$60.81 - $73.36 $28,580 - $34,479
470 Added 0.75%
62,954 $4.62 Million
Q2 2018

Jul 26, 2018
SELL
$57.57 - $63.54 $51,525 - $56,868
-895 Reduced 1.41%
62,484 $3.81 Million
Q1 2018

Apr 26, 2018
BUY
$56.27 - $63.62 $106,913 - $120,878
1,900 Added 3.09%
63,379 $3.8 Million
Q4 2017

Feb 01, 2018
BUY
$53.68 - $57.47 $3.3 Million - $3.53 Million
61,479
61,479 $3.51 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Allied Investment Advisors, LLC Portfolio

Follow Allied Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allied Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allied Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email